Marathon Capital Management
Source: SEC Form 13F · as of Mar 2026Marathon Capital Management holds 19 biotech & pharma companies tracked by BioSniper, totaling $49.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$49.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ASTRAZENECA PLC (AZN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| AZNASTRAZENECA PLC | 65,175 | $12.9M |
| JNJJOHNSON & JOHNSON | 25,288 | $6.2M |
| ADMAADMA BIOLOGICS, INC. | 627,388 | $5.7M |
| ANIPANI PHARMACEUTICALS INC | 72,590 | $5.6M |
| ZTSZoetis Inc. | 35,836 | $4.2M |
| NVONovo Nordisk A/S | 81,564 | $3.0M |
| MRKMerck & Co., Inc. | 23,685 | $2.8M |
| LLYELI LILLY & Co | 2,545 | $2.3M |
| ABBVAbbVie Inc. | 6,832 | $1.5M |
| AMGNAMGEN INC | 2,533 | $891K |
| GEHCGE HealthCare Technologies Inc. | 12,079 | $860K |
| BMYBRISTOL MYERS SQUIBB CO | 8,324 | $505K |
| ABTABBOTT LABORATORIES | 4,705 | $483K |
| CYRXCryoport, Inc. | 57,225 | $474K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 151,295 | $464K |
| PFEPFIZER INC | 16,345 | $459K |
| RPRXRoyalty Pharma plc | 8,977 | $431K |
| ELVElevance Health Inc. | 1,190 | $348K |
| DYAIDYADIC INTERNATIONAL INC | 110,000 | $90K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.